Adam S. Grossman
2022
In 2022, Adam S. Grossman earned a total compensation of $2.6M as Director, President and Chief Executive Officer at ADMA Biologics, a 39% decrease compared to previous year.
Compensation breakdown
| Bonus | $837,351 |
|---|---|
| Option Awards | $629,064 |
| Salary | $636,540 |
| Stock Awards | $501,000 |
| Other | $45,545 |
| Total | $2,649,501 |
Grossman received $837.4K in bonus, accounting for 32% of the total pay in 2022.
Grossman also received $629.1K in option awards, $636.5K in salary, $501K in stock awards and $45.5K in other compensation.
Rankings
In 2022, Adam S. Grossman's compensation ranked 1,384th out of 5,736 executives tracked by ExecPay. In other words, Grossman earned more than 75.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,384 out of 5,736 | 76th |
Division Manufacturing | 688 out of 3,125 | 78th |
Major group Chemicals And Allied Products | 261 out of 1,416 | 82nd |
Industry group Drugs | 240 out of 1,317 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 61 out of 291 | 79th |
Source: SEC filing on April 13, 2023.
Grossman's colleagues
We found one more compensation record of an executive who worked with Adam S. Grossman at ADMA Biologics in 2022.
2022
Brian Lenz
ADMA Biologics
Chief Financial Officer
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019